top of page
Writer's pictureLev Mikulitski

Tackling Antimicrobial Resistance (AMR): A Global Health Crisis and the Future Solutions.

Antimicrobial resistance (AMR) is one of the most significant and urgent public health challenges we face today. It is estimated that over 1.27 million people die annually from infections caused by resistant bacteria, with nearly 5 million deaths globally linked to AMR in some capacity. The rise of AMR threatens to reverse decades of medical progress, rendering common infections, surgeries, and even cancer treatments more dangerous and harder to treat. The global impact is far-reaching, as AMR is not confined to human health but also threatens food security, economic stability, and the environment.


antimicrobial resistance (AMR)
antimicrobial resistance (AMR)

The Global Challenge of AMR


The global rise in AMR is driven by several factors, with the overuse and misuse of antibiotics in both human medicine and agriculture being the leading contributors. For example, the World Health Organization (WHO) has pointed out that antibiotic over-prescription, poor hygiene, and inadequate infection control in healthcare facilities are key drivers of the problem. Furthermore, in agriculture, the routine use of antibiotics in animal husbandry to promote growth or prevent disease in healthy animals has fueled the rise of resistant bacteria that can be transmitted to humans via food consumption or direct contact with animals.


The situation is even more dire in low-income countries where lack of access to clean water, inadequate sanitation, and poor healthcare infrastructure exacerbate the problem. These countries, where people are often prescribed antibiotics without appropriate diagnosis, are seeing a faster pace of resistance development.


While AMR is primarily a health issue, it is deeply interconnected with global food security. In low-income countries, where small-scale farmers rely on livestock for income, the spread of AMR among animals can lead to decreased agricultural productivity, potentially increasing food insecurity. AMR-related crop failures due to resistance in microbial populations affecting soil health and plant growth can compound the issue.


The Global Developments in Combating AMR


In recent years, there has been increased awareness and action at the international level. The United Nations (UN) and the World Health Organization (WHO) have made AMR one of their primary health priorities, urging countries to adopt national action plans for tackling AMR. The Global Action Plan on AMR, endorsed by the WHO in 2015, advocates for a One Health approach—integrating human, animal, and environmental health to combat resistance in a holistic manner.


In response, many countries are making strides toward reducing antibiotic use in farming, implementing stricter regulations on the prescription of antibiotics, and increasing investment in surveillance systems to monitor the spread of resistant bacteria. The European Union has implemented measures such as banning the use of antibiotics for growth promotion in animals, and countries like Sweden have successfully reduced antimicrobial use in livestock while maintaining high agricultural productivity.


However, despite these efforts, AMR continues to accelerate, and new approaches are required to make significant progress.


Innovative Solutions to Combat AMR


While traditional efforts to combat AMR—such as improving antibiotic stewardship, enhancing infection control, and reducing antibiotic misuse—are essential, we also need to look toward cutting-edge technologies that can tackle AMR at its roots. Here are two innovative solutions that are currently being researched and hold great promise for the future:


1. Bacteriophage Therapy: The Resurgence of "Good Viruses"


One of the most promising and unexpected solutions to AMR is the use of bacteriophages—viruses that specifically target and kill bacteria. Bacteriophages have been used for nearly a century in countries like Georgia and Russia but have largely been sidelined by the development of antibiotics. Now, with the advancement of synthetic biology and genomic sequencing, bacteriophages are being re-engineered to target antibiotic-resistant bacteria with remarkable precision.


Bacteriophage therapy could be a game-changer, especially in regions where traditional antibiotics are losing their effectiveness. Unlike antibiotics, which can cause collateral damage to beneficial bacteria, phages selectively target harmful bacteria while leaving healthy microbiota intact. What’s more, phages are capable of adapting to bacterial mutations, making them highly effective against evolving resistant strains.


Several biotech companies, such as Phage Biotech and Intralytix, are leading the charge in developing bacteriophage treatments. The use of bacteriophages in agriculture is also being explored to target bacterial infections in livestock without the use of antibiotics. This could significantly reduce the need for antibiotics in farming, slowing the spread of resistant bacteria in both animals and humans.


2. Artificial Intelligence (AI) in Antimicrobial Discovery


Another breakthrough solution to combat AMR lies in the integration of artificial intelligence (AI) with drug discovery. AI algorithms have the potential to revolutionize the process of discovering new antimicrobial agents by analyzing vast datasets of molecular interactions and predicting the most effective compounds. AI can model interactions between molecules and bacteria in a way that humans cannot, drastically speeding up the discovery process.


Companies like Ginkgo Bioworks and IBM’s Watson Health are already applying AI to design new antibiotics and antimicrobial agents. For example, IBM Watson Health has partnered with Merck and Insilico Medicine to use AI to discover antibiotics that target multidrug-resistant organisms. Machine learning models can predict how bacteria will evolve and even identify natural compounds that may have been overlooked by traditional methods.


This AI-driven approach could lead to the discovery of entirely new classes of antibiotics that are more effective and less likely to induce resistance. Moreover, AI’s ability to tailor treatments based on genetic and microbial data could pave the way for personalized treatments for resistant infections, making the fight against AMR not just a global challenge but a highly targeted one.


The Way Forward: A Multi-Pronged Approach


Addressing AMR requires a multi-disciplinary approach involving cooperation between governments, healthcare providers, agricultural sectors, and the scientific community. While these new technologies—bacteriophage therapy and AI-driven antimicrobial discovery—hold tremendous promise, they must be integrated into broader strategies that include improved infection control practices, enhanced diagnostic capabilities, and global surveillance systems.


Moreover, solutions must be accessible to low- and middle-income countries, where the burden of AMR is most acute. Global partnerships between private companies, non-governmental organizations (NGOs), and international health organizations will be essential in ensuring equitable access to these novel technologies.


The challenge is massive, but with sustained investment in research and innovation, and a unified global effort, we can make meaningful progress. The success of this mission depends not only on technological breakthroughs but also on our collective ability to shift societal attitudes, invest in sustainable solutions, and embrace innovative approaches to AMR.


Conclusion: The Need for Urgent Action


AMR is one of the greatest threats to public health today, but it is not an insurmountable challenge. By embracing innovative technologies, supporting sustainable agriculture practices, and investing in global collaboration, we can turn the tide against this silent pandemic. The future of AMR combat lies not just in what we know, but in what we are willing to discover and implement. The time to act is now, and the solutions of tomorrow are already within our reach.


 

References

  • World Health Organization (WHO), “Antimicrobial Resistance,” 2021.

  • CDC, “Antimicrobial Resistance Threats in the United States,” 2019.

  • Ginkgo Bioworks, “AI and the Future of Antibiotics,” 2020.

  • Phage Biotech, “Bacteriophage Therapy as a Solution for AMR,” 2021.

14 views0 comments

Comments


bottom of page